Medtronic Cardiovascular

medtronic.com

Live pipeline data from ClinicalTrials.gov, refreshed daily.

Total trials

69

Active

16

Phase 3

2

Total enrollment

26,082

Pipeline matrix

Showing 0 of 0 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal

Next readouts

No upcoming readouts found.

Top conditions

  • Aortic Valve Stenosis10
  • Aortic Aneurysm, Abdominal5
  • Severe Aortic Stenosis4
  • Aortic Aneurysm, Thoracic4
  • Heart Valve Diseases4
  • Abdominal Aortic Aneurysms3
  • Abdominal Aortic Aneurysm3
  • Aortic Stenosis3

Frequently asked questions about Medtronic Cardiovascular

How many clinical trials does Medtronic Cardiovascular have on ClinicalTrials.gov?
Medtronic Cardiovascular is listed as the lead sponsor on 69 clinical trials in ClinicalTrials.gov, 16 of which are currently active (recruiting, enrolling, or ongoing).
How many of Medtronic Cardiovascular's trials are in Phase 3?
2 of Medtronic Cardiovascular's trials are in Phase 3.
What therapeutic areas does Medtronic Cardiovascular focus on?
Medtronic Cardiovascular's most-studied conditions on ClinicalTrials.gov are Aortic Valve Stenosis, Aortic Aneurysm, Abdominal, Severe Aortic Stenosis, Aortic Aneurysm, Thoracic, Heart Valve Diseases.